Stryker Debt to Equity Ratio 2006-2018 | SYK

Current and historical debt to equity ratio values for Stryker (SYK) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Stryker debt/equity for the three months ending September 30, 2018 was 0.60.
Stryker Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $5.93B $9.86B 0.60
2018-06-30 $5.93B $9.46B 0.63
2018-03-31 $5.92B $9.22B 0.64
2017-12-31 $6.59B $9.98B 0.66
2017-09-30 $6.59B $10.43B 0.63
2017-06-30 $6.59B $10.04B 0.66
2017-03-31 $7.18B $9.70B 0.74
2016-12-31 $6.69B $9.55B 0.70
2016-09-30 $6.71B $9.33B 0.72
2016-06-30 $6.72B $9.10B 0.74
2016-03-31 $6.71B $8.81B 0.76
2015-12-31 $3.23B $8.51B 0.38
2015-09-30 $2.51B $8.48B 0.30
2015-06-30 $3.24B $8.51B 0.38
2015-03-31 $3.26B $8.32B 0.39
2014-12-31 $3.25B $8.60B 0.38
2014-09-30 $3.23B $8.62B 0.38
2014-06-30 $3.24B $9.00B 0.36
2014-03-31 $2.24B $9.06B 0.25
2013-12-31 $2.74B $9.05B 0.30
2013-09-30 $2.74B $8.74B 0.31
2013-06-30 $2.74B $8.60B 0.32
2013-03-31 $2.74B $8.46B 0.32
2012-12-31 $1.75B $8.60B 0.20
2012-09-30 $1.75B $8.36B 0.21
2012-06-30 $1.75B $7.95B 0.22
2012-03-31 $1.75B $8.02B 0.22
2011-12-31 $1.75B $7.68B 0.23
2011-09-30 $1.76B $7.56B 0.23
2011-06-30 $1.00B $7.78B 0.13
2011-03-31 $1.00B $7.45B 0.13
2010-12-31 $1.00B $7.17B 0.14
2010-09-30 $1.00B $7.31B 0.14
2010-06-30 $1.00B $6.75B 0.15
2010-03-31 $1.00B $6.67B 0.15
2009-12-31 $0.00B $6.60B 0.00
2009-09-30 $0.00B $6.44B 0.00
2009-06-30 $0.00B $6.06B 0.00
2009-03-31 $0.00B $5.63B 0.00
2008-12-31 $0.00B $5.41B 0.00
2008-09-30 $0.00B $5.75B 0.00
2008-06-30 $0.00B $6.22B 0.00
2008-03-31 $0.00B $5.93B 0.00
2007-12-31 $0.00B $5.38B 0.00
2007-09-30 $0.00B $5.16B 0.00
2007-06-30 $0.00B $4.80B 0.00
2007-03-31 $0.00B $4.49B 0.00
2006-12-31 $0.00B $4.19B 0.00
2006-09-30 $0.00B $3.99B 0.00
2006-06-30 $0.00B $3.77B 0.00
2006-03-31 $0.10B $3.49B 0.03
2005-12-31 $0.18B $3.30B 0.06
2005-09-30 $0.00B $3.11B 0.00
2005-06-30 $0.00B $2.99B 0.00
2005-03-31 $0.00B $2.90B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $62.096B $12.444B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $124.463B 18.51
Abbott Laboratories (ABT) United States $121.292B 24.58
Boston Scientific (BSX) United States $47.118B 23.81
Baxter (BAX) United States $34.153B 22.06
Zimmer Biomet Holdings (ZBH) United States $22.927B 14.87
Smith & Nephew SNATS (SNN) United Kingdom $15.749B 0.00
ResMed (RMD) United States $14.479B 27.61
Perrigo (PRGO) Ireland $8.210B 12.46
Bio-Rad Laboratories (BIO) United States $7.933B 50.72
Canopy Growth (CGC) Canada $7.466B 0.00
Hill-Rom Holdings (HRC) United States $6.097B 19.08
Aurora Cannabis (ACB) Canada $5.815B 31.74
Haemonetics (HAE) United States $5.279B 46.42
ICU Medical (ICUI) United States $4.777B 26.62
Insulet (PODD) United States $4.449B 0.00
Hutchison China MediTech (HCM) China $4.244B 0.00
Agios Pharmaceuticals (AGIO) United States $3.828B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.656B 0.00
Neogen (NEOG) United States $3.174B 48.06
NuVasive (NUVA) United States $3.162B 29.43
National Vision Holdings (EYE) United States $2.783B 53.82
Quidel (QDEL) United States $2.312B 30.14
Aphria (APHA) $2.200B 0.00
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.381B 19.54
AtriCure (ATRC) United States $1.208B 0.00
Cardiovascular Systems (CSII) United States $1.049B 1511.50
VAREX IMAGING (VREX) United States $0.923B 18.53
OraSure Technologies (OSUR) United States $0.783B 44.10
Meridian Bioscience (VIVO) United States $0.780B 24.86
Surmodics (SRDX) United States $0.738B 112.75
PetIQ (PETQ) United States $0.733B 20.83
Cerus (CERS) United States $0.710B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.709B 22.76
MacroGenics (MGNX) United States $0.706B 0.00
Omeros (OMER) United States $0.632B 0.00
Lantheus Holdings (LNTH) United States $0.616B 19.06
LeMaitre Vascular (LMAT) United States $0.533B 26.19
Owens & Minor (OMI) United States $0.525B 5.94
NanoString Technologies (NSTG) United States $0.506B 0.00
Insys Therapeutics (INSY) United States $0.480B 0.00
TG Therapeutics (TGTX) United States $0.405B 0.00
Evolus (EOLS) United States $0.378B 0.00
Quanterix (QTRX) United States $0.370B 0.00
Utah Medical Products (UTMD) United States $0.344B 22.27
Cytosorbents (CTSO) United States $0.309B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.248B 0.00
Surface Oncology (SURF) United States $0.227B 0.00
Rockwell Medical (RMTI) United States $0.199B 0.00
Bovie Medical (BVX) United States $0.195B 0.00
BioLife Solutions (BLFS) United States $0.193B 261.25
Chimerix (CMRX) United States $0.167B 0.00
Fonar (FONR) United States $0.137B 6.90
Conatus Pharmaceuticals (CNAT) United States $0.135B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.113B 0.00
Chembio Diagnostics (CEMI) United States $0.104B 0.00
United-Guardian (UG) United States $0.079B 16.64
Female Health (VERU) United States $0.073B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.072B 0.00
InfuSystems Holdings (INFU) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.061B 19.53
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.047B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.026B 0.00
Myomo (MYO) United States $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.020B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Senestech (SNES) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00